Watkins Tim — SEC Form 4 filings
SEC reporting owner CIK 2065965. 5 Form 4 filings on record with FilingPulse; latest filed 2026-07-01.
Transaction summary — filings shown
Covers all 5 filings on record, filed 2025-04-28 to 2026-07-01. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 5 legs across 4 filings — 21,666 shares, $322,557 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 11.
- Largest priced transaction: sale of 10,833 shares @ $16.02 ($173,590) in Contineum Therapeutics, Inc., filed 2026-07-01.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Contineum Therapeutics, Inc. (CTNM) | CMO & Head of Development | 5 | — | 5 legs · 21,666 sh · $322,557 | 11 |
Form 4 filings — Watkins Tim
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-01 | 4 | Contineum Therapeutics, Inc. (CTNM) | Option exercise (M): 10,833 @ $4.50 · Sale (S): 10,833 @ $16.02 · Option exercise (M): 10,833 (derivative) @ $0 | EDGAR |
| 2026-03-02 | 4 | Contineum Therapeutics, Inc. (CTNM) | Option exercise (M): 3,611 @ $4.50 · Sale (S): 3,611 @ $15.02 · Option exercise (M): 3,611 (derivative) @ $0 | EDGAR |
| 2026-01-30 | 4 | Contineum Therapeutics, Inc. (CTNM) | Option exercise (M): 3,611 @ $4.50 · Sale (S): 2,800 @ $14.09 · Sale (S): 811 @ $14.48 · Option exercise (M): 3,611 (derivative) @ $0 · Grant/award (A): 160,000 (derivative) @ $0 | EDGAR |
| 2025-12-30 | 4 | Contineum Therapeutics, Inc. (CTNM) | Option exercise (M): 3,611 @ $4.50 · Sale (S): 3,611 @ $12.06 · Option exercise (M): 3,611 (derivative) @ $0 | EDGAR |
| 2025-04-28 | 4 | Contineum Therapeutics, Inc. (CTNM) | Grant/award (A): 260,000 (derivative) @ $0 · Grant/award (A): 26,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2065965 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →